2017 | Philochem

Philogen announces the authorisation of a clinical trial with PHC-102 for the imaging of renal cell carcinoma.

by last | Oct 19, 2017 | 2017, Press Releases

Philogen announces the authorisation of a clinical trial with PHC-102 for the imaging of renal cell carcinoma

Philochem announces a publication entitled: “Impact of a Central Scaffold on the Binding Affinity of Fragment Pairs Isolated from DNA‐Encoded Self‐Assembling Chemical Libraries”

by last | Sep 24, 2017 | 2017, Press Releases

Philochem announces a publication entitled: “Impact of a Central Scaffold on the Binding Affinity of Fragment Pairs Isolated from DNA‐Encoded Self‐Assembling Chemical Libraries” Link to Paper

Philogen announces research collaboration with Servier in the field of DNA-encoded chemistry.

by last | Aug 25, 2017 | 2017, Press Releases

Press release Philogen_Servier

Philochem announces a publication entitled: “Data-Independent Acquisition of HLA Class I Peptidomes on the Q Exactive Mass Spectrometer Platform”

by last | Aug 18, 2017 | 2017, Press Releases

Philochem announces a publication entitled: “Data-Independent Acquisition of HLA Class I Peptidomes on the Q Exactive Mass Spectrometer Platform” Link to Paper

Philogen S.p.A. enters into Multi-Target research agreement with Boehringer Ingelheim in the field of DNA-encoded chemistry.

by last | Jul 20, 2017 | 2017, Press Releases

Press release Philogen_20 Juy 2017

Philogen S.p.A. announces participation to the ““FOCIS Annual Meeting 2017”, June 14 – 17, 2017, Chicago, USA

by last | May 25, 2017 | 2017, Press Releases

PR_FOCIS 2017